AEVIS (AEVIS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
26 May, 2026Executive summary
Consolidated revenues reached CHF 329.7 million in Q1 2025, up 17.0% year-over-year.
Organic growth in operating divisions was 3.2%, with further momentum from acquisitions.
Operations performed as expected, with acquisitions from 2024 supporting ongoing growth.
Financial highlights
Revenue increased to CHF 329.7 million in Q1 2025 from CHF 281.9 million in Q1 2024.
Swiss Medical Network SA revenue rose 21.4% to CHF 258.6 million.
MRH Switzerland AG revenue grew 3.7% to CHF 67.1 million.
Real Estate and Others contributed CHF 4.1 million, slightly down from CHF 4.3 million.
Outlook and guidance
Full-year growth rate is expected to be maintained, supported by 2024 acquisitions.
Additional income from non-strategic real estate disposals anticipated for the rest of 2025.
Latest events from AEVIS
- NAV per share up 6.8% to CHF 26.75; profit and margins rose; Infracore IPO boosted liquidity.AEVIS
H1 2026 - Integrated healthcare, hospitality, and real estate drive growth, margin gains, and long-term value.AEVISCMD 2026 presentation
- Acquisition for CHF 50M in shares and CHF 70M debt drives CHF 100M revenue boost in 2025.AEVISM&A announcement
- Revenue and EBITDAR surged, with net profit rebounding and strong segment growth.AEVISH1 2024
- Revenue grew 7.1% year-over-year, driven by strong healthcare, hospitality, and real estate gains.AEVISQ3 2024
- Net profit rebounded to CHF 26.5 million, with robust growth and improved capital strength.AEVISH2 2024
- H1-2025 saw revenue up 17.9%, strong margins, and debt cut by over CHF 120m.AEVISH1 2025
- Revenue up 18.2% year-over-year, with strong growth in Healthcare, Hospitality, and Real Estate.AEVISQ3 2025
- Revenue up 13.5% to CHF 1,055.1m, with deleveraging and margin improvement across segments.AEVISH2 2025